Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.

Ebubekir Şenateş, Yaşar Çolak, Onur Şahi̇n, Özlem TİMİRCİ KAHRAMAN, Banu Erkalma Şenateş, İbrahim Tuncer

PubMed · 2012 · 41 citations · 0 references

Abstract

Our data suggest that resistin levels are elevated in patients with NAFLD and could discriminate simple steatosis from definite NASH.